Bath & Body Works (NYSE:BBWI) Stock Gets Price Target Reduction from BMO Capital Markets

Bath & Body Works (NYSE:BBWI – Get Free Report) had its price target decreased by equities research analysts at BMO Capital Markets from $24.00 to $20.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has a “market perform” rating on the stock. BMO Capital Markets‘s target price points to a potential upside of 5.62% from the stock’s previous close.

BBWI has been the subject of several other research reports. Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Tuesday, October 6th. Barclays lowered their price objective on shares of Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 27th. JPMorgan Chase & Co. boosted their target price on shares of Bath & Body Works from $22.00 to $24.00 and gave the company a “neutral” rating in a research note on Tuesday, August 18th. Bank of America set a $25.00 target price on Bath & Body Works and gave the company a “buy” rating in a report on Friday. Finally, UBS Group raised their target price on Bath & Body Works from $17.00 to $22.00 and gave the stock a “neutral” rating in a research report on Friday, November 13th. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $22.27.

Check Out Our Latest Analysis on BBWI

Bath & Body Works Price Performance

NYSE BBWI traded up $0.03 on Friday, hitting $18.93. 1,828,155 shares of the company were exchanged, compared to its average volume of 6,023,616. The company’s 50 day moving average price is $19.24 and its 200-day moving average price is $19.77. The firm has a market capitalization of $3.82 billion, a P/E ratio of 4.96, a price-to-earnings-growth ratio of 0.93 and a beta of 1.31. Bath & Body Works has a twelve month low of $14.27 and a twelve month high of $24.94.

Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its earnings results on Thursday, November 19th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.12 by $0.14. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.55 billion. During the same period last year, the company posted $0.37 earnings per share. The business’s revenue for the quarter was down 1.1% on a year-over-year basis. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities analysts expect that Bath & Body Works will post 2.74 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. acquired a new position in Bath & Body Works in the 2nd quarter valued at approximately $449,065,000. Bank of America Corp DE acquired a new stake in shares of Bath & Body Works during the 2nd quarter valued at $62,249,000. Bank of New York Mellon Corp purchased a new position in shares of Bath & Body Works during the 2nd quarter valued at $59,260,000. Marshall Wace LLP grew its holdings in shares of Bath & Body Works by 458.9% during the 3rd quarter. Marshall Wace LLP now owns 3,260,323 shares of the company’s stock valued at $51,904,000 after acquiring an additional 2,677,026 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership grew its holdings in shares of Bath & Body Works by 34.2% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,777,576 shares of the company’s stock valued at $51,857,000 after acquiring an additional 707,449 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Bath & Body Works

Investors following BBWI have been watching these stories:

  • Positive Sentiment: Third-quarter adjusted EPS was $0.26, above the $0.12 consensus, and revenue of $1.58 billion topped expectations. The company also raised its full-year sales outlook, citing progress in digital and wholesale channels. Third-quarter results and updated outlook
  • Neutral Sentiment: Wells Fargo, Morgan Stanley and Baird each lowered their price targets, but retained their respective Overweight, Equal Weight and Neutral ratings. Their revised targets remain above the recent share price, indicating mixed views rather than a broad downgrade. Wells Fargo rating
  • Negative Sentiment: The fourth-quarter EPS outlook of $1.41–$1.61 is below analysts’ $1.72 estimate, and revenue guidance also falls short of consensus at its upper end. Management warned of softer holiday sales; quarterly revenue and EPS were also below year-ago levels. This cautious near-term outlook may overshadow the earnings beat and higher full-year sales forecast. Holiday sales outlook

Bath & Body Works Company Profile

(Get Free Report)

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

Further Reading

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.